HIV-1 pretreatment drug resistance and genetic transmission network in the southwest border region of China

被引:11
|
作者
Li, Difei [1 ]
Chen, Huichao [2 ]
Li, Huilan [3 ]
Ma, Yanling [2 ]
Dong, Lijuan [2 ]
Dai, Jie [2 ]
Jin, Xiaomei [2 ]
Yang, Min [2 ]
Zeng, Zhijun [2 ]
Sun, Pengyan [2 ]
Song, Zhizhong [2 ]
Chen, Min [2 ]
机构
[1] Kunming Med Univ, Sch Publ Hlth, Kunming, Yunnan, Peoples R China
[2] Yunnan Ctr Dis Control & Prevent, Inst AIDS STD Control & Prevent, 158 Dongsi St, Kunming 650022, Yunnan, Peoples R China
[3] Puer Ctr Dis Control & Prevent, Div AIDS STD Control & Prevent, Puer, Yunnan, Peoples R China
基金
中国国家自然科学基金;
关键词
HIV; Pretreatment drug resistance; Genetic transmission network; YUNNAN;
D O I
10.1186/s12879-022-07734-3
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background HIV drug resistance increased with the widespread use of antiretroviral drugs, and posed great threat to antiretroviral therapy (ART). Pu'er Prefecture, lying in the southwest of Yunnan Province, China, borders Myanmar, Laos and Vietnam, is also the area where AIDS was discovered earlier, however, in which there has been no information on HIV drug resistance. Methods A cross-sectional survey of pretreatment drug resistance (PDR) was conducted in Pu'er Prefecture in 2021. Partial pol gene sequences were obtained to analyze drug resistance and construct genetic transmission network. HIV drug resistance was analyzed using the Stanford University HIVdb algorithm. Results A total of 295 sequences were obtained, among which 11 HIV-1 strain types were detected and CRF08_BC (62.0%, 183/295) was the predominant one. Drug resistance mutations (DRMs) were detected in 42.4% (125/295) of the sequences. The prevalence of PDR to any antiretroviral drugs, nucleoside reverse transcriptase inhibitors (NRTIs), non-nucleoside reverse transcriptase inhibitors (NNRTIs) and protease inhibitors (PIs) were 10.8% (32/295), 9.5% (28/295), 1.0% (3/295) and 0.3% (1/295), respectively. The risk of PDR occurrence was higher among individuals with CRF01_AE strain types. HIV-1 molecular network was constructed, in which 56.0% (42/75) of links were transregional, and 54.7% (41/75) of links were associated with Lancang County. Among the sequences in the network, 36.8% (35/95) harbored DRMs, and 9.5% (9/95) were drug resistance strains. Furthermore, 8 clusters had shared DRM. Conclusion The overall prevalence of PDR in this study was in a moderate level, but NNRTIs resistance was very approaching to the threshold of public response initiation. PDR was identified in the transmission network, and DRMs transmission was observed. These findings suggested that the consecutive PDR surveillance should be conducted in this region.
引用
收藏
页数:11
相关论文
共 50 条
  • [1] HIV-1 pretreatment drug resistance and genetic transmission network in the southwest border region of China
    Difei Li
    Huichao Chen
    Huilan Li
    Yanling Ma
    Lijuan Dong
    Jie Dai
    Xiaomei Jin
    Min Yang
    Zhijun Zeng
    Pengyan Sun
    Zhizhong Song
    Min Chen
    [J]. BMC Infectious Diseases, 22
  • [2] Survey of Pretreatment HIV Drug Resistance and Genetic Transmission Network Analysis Among HIV Patients in a High Drug-Use Area of Southwest China
    Liu, Lei
    Dong, Aobo
    Liao, Lingjie
    Feng, Yi
    Shao, Yiming
    Liang, Shu
    Ruan, Yuhua
    Xing, Hui
    [J]. CURRENT HIV RESEARCH, 2019, 17 (06) : 441 - 451
  • [3] HIV-1 Drug Resistance Transmission Networks in Southwest Switzerland
    Castro, Erika
    Khonkarly, Mona
    Ciuffreda, Donatella
    Buergisser, Philippe
    Cavassini, Matthias
    Yerly, Sabine
    Pantaleo, Giuseppe
    Bart, Pierre-Alexandre
    [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 2010, 26 (11) : 1233 - 1238
  • [4] HIV-1 Genetic Diversity and High Prevalence of Pretreatment Drug Resistance in Tianjin, China
    Zeng, Rui
    Ren, Doudou
    Gong, Xiaowen
    Wei, Min
    Gao, Liying
    Yu, Aiping
    Zhang, Defa
    Mi, Yuqiang
    Ma, Ping
    [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 2020, 36 (10) : 852 - 861
  • [5] The characteristics of pretreatment HIV-1 drug resistance in western Yunnan, China
    Chen, Min
    Zhu, Qiongmei
    Xing, Hui
    Chen, Huichao
    Jin, Xiaomei
    Dong, Lijuan
    Dai, Jie
    Yang, Min
    Yang, Cuiyun
    Jia, Manhong
    Ma, Yanling
    [J]. EPIDEMIOLOGY AND INFECTION, 2020, 148
  • [6] Using Molecular Transmission Networks to Reveal the Epidemic of Pretreatment HIV-1 Drug Resistance in Guangxi, China
    Zhang, Fei
    Liang, Bingyu
    Liang, Xu
    Lin, Zhaosen
    Yang, Yuan
    Liang, Na
    Yang, Yao
    Liang, Huayue
    Jiang, Jiaxiao
    Huang, Jiegang
    Huang, Rongye
    Zhong, Shanmei
    Qin, Cai
    Jiang, Junjun
    Ye, Li
    Liang, Hao
    [J]. FRONTIERS IN GENETICS, 2021, 12
  • [7] Pretreatment HIV-1 drug resistance in Africa
    Hamers, Raph L.
    Kityo, Cissy
    Sigaloff, Kim C. E.
    de Wit, Tobias F. Rinke
    [J]. LANCET INFECTIOUS DISEASES, 2013, 13 (06): : 476 - 476
  • [8] Transmission of HIV-1 drug resistance
    Tang, JW
    Pillay, D
    [J]. JOURNAL OF CLINICAL VIROLOGY, 2004, 30 (01) : 1 - 10
  • [9] Prevalence and transmission of pretreatment drug resistance in people living with HIV-1 in Shanghai China, 2017-2021
    Zhang, Min
    Ma, Yingying
    Wang, Zhenyan
    Wang, Gang
    Wang, Qianying
    Li, Xin
    Lin, Feng
    Zhang, Chiyu
    [J]. VIRULENCE, 2024, 15 (01)
  • [10] HIV-1 drug resistance and genetic transmission network among newly diagnosed people living with HIV/AIDS in Ningbo, China between 2018 and 2021
    Hong, Hang
    Tang, Chunlan
    Liu, Yuhui
    Jiang, Haibo
    Fang, Ting
    Xu, Guozhang
    [J]. VIROLOGY JOURNAL, 2023, 20 (01)